Illumina Infinium Methylation EPIC v2.0 Kits
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) has issued a Presolicitation / Notice of Intent to award a Firm-Fixed-Price Purchase Order to Illumina, Inc. for Illumina Infinium Methylation EPIC v2.0 Kits. This notice indicates the government's belief that Illumina, Inc. is the only responsible source. However, small businesses are invited to submit capability statements demonstrating their ability to fulfill the requirement. Responses are due by June 5, 2026, at 11:00 p.m. EDT.
Purpose & Scope
This opportunity is for the procurement of Illumina Infinium Methylation EPIC v2.0 arrays, which are critical tools for intramural scientific and clinical research focused on epigenetic mechanisms underlying human health and disease. These kits are specifically used for DNA analysis of samples and are essential for combining results with previous research. Illumina, Inc. is identified as the sole designer, manufacturer, and distributor, with no alternative vendor capable of supplying a product with the same information content compatible with existing systems.
Contract Details
The intended award is a Firm-Fixed-Price Purchase Order. The place of performance is Bethesda, MD 20892.
Set-Aside & Eligibility
This is not a competitive solicitation. The government intends to award on a sole-source basis. However, small businesses (including 8(a), service-disabled veteran owned, HUBZone, small disadvantaged, veteran-owned, and women-owned businesses) are encouraged to submit a written capability statement. This statement should clearly demonstrate their ability to perform the requirement.
Submission & Evaluation
This notice is not a request for competitive quotes. The determination to compete the award based on submitted responses is at the Government's discretion. Capability statements must be submitted via email to david.shen@nih.gov no later than June 5, 2026, at 11:00 p.m. EDT. An award is anticipated approximately ten days after the notice date, unless another vendor successfully demonstrates capability.
Timeline
- Published Date: May 28, 2026
- Response Due: June 5, 2026, 11:00 p.m. EDT